# Ken Life Care · 66-41 · INDIA — FDA import alert red lists: firms subject to detention without physical examination For Ken Life Care · 66-41 · INDIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is INDIA; product is Resfriol Vapour Inhaler | Resfriol Vapour Inhaler | Resfriol Vapour Inhaler; product code is 62 U - - 99 Anti-Tussive/Cold N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 77 K - - CO Inhaler, Nasal; date published is 11/20/2018; address is 3 1 Plot No 13 , Kumedi , Indore, Madhya Pradesh INDIA, verified against its source on 2026-09-16. - **Firm:** Ken Life Care _(verified: appears in the quote below)_ - **Import alert:** 66-41 - **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S. - **Country:** INDIA _(verified: appears in the quote below)_ - **Address:** 3 1 Plot No 13 , Kumedi , Indore, Madhya Pradesh INDIA _(verified: appears in the quote below)_ - **Date published:** 11/20/2018 _(verified: appears in the quote below)_ - **Product code:** 62 U - - 99 Anti-Tussive/Cold N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. | 77 K - - CO Inhaler, Nasal _(verified: each item appears in the quote below)_ - **Product:** Resfriol Vapour Inhaler | Resfriol Vapour Inhaler | Resfriol Vapour Inhaler _(verified: each item appears in the quote below)_ ## What the source says > Ken Life Care Date Published : 11/20/2018 3 1 Plot No 13 , Kumedi , Indore, Madhya Pradesh INDIA 62 U - - 99 Anti-Tussive/Cold N.E.C. Date Published: 11/20/2018 Desc: Resfriol Vapour Inhaler 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 11/20/2018 Desc: Resfriol Vapour Inhaler 77 K - - CO Inhaler, Nasal Date Published: 11/20/2018 Desc: Resfriol Vapour Inhaler ## Source - https://www.accessdata.fda.gov/cms_ia/importalert_190.html Last verified: 2026-09-16. Review by: 2026-11-15. Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).